H5N1 influenza viruses: facts, not fear.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

36 citing papers in PubMed, 75 citations in OpenAlex.

1. An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.Clinical and vaccine immunology : CVI · 2013
   Trial
2. Deliberating the scientific evidence base for influenza transmission to raw milk consumers.Risk analysis : an official publication of the Society for Risk Analysis · 2025
   Review
3. Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?mBio · 2021
   Article
4. A novel framework for inferring parameters of transmission from viral sequence data.PLoS genetics · 2018
   Article
5. Influenza.Nature reviews. Disease primers · 2018
   Review
6. Why Do Exceptionally Dangerous Gain-of-Function Experiments in Influenza?Methods in molecular biology (Clifton, N.J.) · 2018
   Review
7. Does influenza pandemic preparedness and mitigation require gain-of-function research?Influenza and other respiratory viruses · 2017
   Article
8. Viral factors in influenza pandemic risk assessment.eLife · 2016
   Article
9. Mapping influenza transmission in the ferret model to transmission in humans.eLife · 2015
   Article
10. Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients.mBio · 2015
    Article
11. Studies on influenza virus transmission between ferrets: the public health risks revisited.mBio · 2015
    Article
12. Moratorium on research intended to create novel potential pandemic pathogens.mBio · 2014
    Article
13. Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion.mBio · 2014
    Article
14. From cases to capacity? A critical reflection on the role of 'ethical dilemmas' in the development of dual-use governance.Science and engineering ethics · 2014
    Article
15. Ethical alternatives to experiments with novel potential pandemic pathogens.PLoS medicine · 2014
    Article
16. Emerging antiviral strategies to interfere with influenza virus entry.Medicinal research reviews · 2014
    Review
17. H5N1 vaccines in humans.Virus research · 2013
    Review
18. Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1.Influenza and other respiratory viruses · 2013
    Article
19. Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis.Science China. Life sciences · 2013
    Review
20. Editorial commentary: pandemic H5N1: receding risk or coming catastrophe?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article

Corrections and comments

• Commented on by
  H5N1 influenza virus seroepidemiological studies: the facts revisited.2012

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as